NGNE Price / Book | Neurogene Inc.

Neurogene Inc. (NGNE) Price / Book

2026-09-03: Price/Book Ratio 3.46.
2026-06-30: Price/Book Ratio 2.29.
2026-03-31: Price/Book Ratio 1.32.
2025-12-31: Price/Book Ratio 1.2.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-03-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	3.46
2026-06-30	2.29
2026-03-31	1.32
2025-12-31	1.2
2025-09-30	0.96
2025-06-30	0.78
2025-03-31	0.6
2024-12-31	1.09
2024-09-30	3.97
2024-06-30	3.05
2024-03-31	3.83
2023-12-31	1.34
2022-09-30	5.16
2022-06-30	7.52
2022-03-31	12.28
2021-09-30	39.62
2021-06-30	46.87
2021-03-31	58.23
2020-12-31	62.23
2020-09-30	50.17
2020-06-30	99.28
2020-03-31	63.72
2019-12-31	66.08
2019-09-30	23.98
2019-06-30	15.36
2019-03-31	17.73
2018-12-31	13.99
2018-09-30	17.98
2018-06-30	13.76
2018-03-31	77.08
2017-12-31	55.83
2017-09-30	58.37
2017-06-30	52.99
2017-03-31	57.09
2016-12-31	53.46
2016-09-30	40.28
2016-06-30	24.75
2016-03-31	29.65
2015-12-31	39.62
2015-09-30	42.48
2015-06-30	57.69
2015-03-31	58.61
2014-12-31	44.38
2014-09-30	32.39
2014-06-30	40.25
2014-03-31	1.39

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
CorMedix Inc. (CRMD)	United States	$0.605B	3.25
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
ZEVRA THERAPEUTICS, INC. (ZVRA)	United States	$0.668B	14.61
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76